ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2010)

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2010)

EMCREG–International is pleased to present this complimentary CME monograph covering the proceedings of our 2010 webcasts. The events and this monograph covered important current and emerging acute care topics including risk stratification of ACS, ACS anticoagulation, thienopyridine therapy, novel antiplatelet agents prasugrel and ticagrelor, hypertensive emergencies, the obesity epidemic, acute heart failure treatment, and acute stroke.

Read More

HEART FAILURE: BIOMARKERS OF DIAGNOSIS AND PROGNOSIS

HEART FAILURE: BIOMARKERS OF DIAGNOSIS AND PROGNOSIS

Heart Failure remains a common presentation in the emergency department. For the emergency physician clarifying the course of the universal complaint, shortness of breath, requires excellent clinical acumen combined with a clear understanding of the laboratory tests available to distinguish Heart Failure from other causes of dyspnea. Dr. Frank Peacock of the Cleveland Clinic authors an excellent discussion of the scientific basis for the use of the natriuretic peptide biomarkers in heart failure including future markers currently being investigated.

Read More

CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES AND POINT-OF-CARE TESTING

CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES AND POINT-OF-CARE TESTING

The Emergency Medicine Cardiac Research and Education Group (EMCREG)-International is pleased to present this monograph representing the proceedings of our satellite symposium at the ACEP Scientific Assembly in Washington, DC, in late September of 2005. In this monograph, you will find a variety of important topics covered including the CRUSADE Quality Improvement Initiative, clopidogrel’s use in ST-segment elevation myocardial infarction, low molecular weight heparins in acute coronary syndromes, dyslipidemia, diagnosis and treatment on acute decompensated heart failure, evaluation of pulmonary embolism, cardiac biomarkers in point-of-care testing, the Stroke Center certification concept, evaluation of transient ischemic attacks, and the role of serum biomarkers in the diagnosis of stroke.

Read More

THE ROLE OF NESIRITIDE IN THE MANAGEMENT OF ADHF: REVIEW OF MORTALITY DATA AND RECOMMENDATIONS FOR CLINICAL USE

THE ROLE OF NESIRITIDE IN THE MANAGEMENT OF ADHF: REVIEW OF MORTALITY DATA AND RECOMMENDATIONS FOR CLINICAL USE

In this EMCREG-International newsletter, J. Douglas Kirk, MD, Associate Professor of Emergency Medicine at UC Davis Sacramento, CA discusses the current data regarding nesiritide which provides perspective on this controversial issue for the practicing emergency physician.

Read More

EMERGENCY DIAGNOSIS AND TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE (ADHF)

EMERGENCY DIAGNOSIS AND TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE (ADHF)

Each year, nearly one million patients in the United States are hospitalized with acute decompensated heart failure (ADHF). In the past, there have been limited practice guidelines for the emergency management of ADHF within the spectrum of heart failure. Data from the ADHERE (the acute decompensated heart failure national registry),indicates that these patients are repeatedly hospitalized, and otherwise have a very high rate of morbidity and mortality. The management and care of this patient group remains suboptimal. This CME activity will review the latest diagnostic and therapeutic modalities for ADHF and suggest methods to improve the care for these patients at your institution. Insights and lessons from ADHERE will also be reviewed and discussed.

Read More